In Vitro Protein Expression Market - Global Industry Analysis, Size, Share, Growth, Trends, & Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America & Middle East & Africa)

Description

The global in vitro protein expression market is set to experience substantial growth, reaching a significant value by the conclusion of the assessment period. Over the years 2019-2023, the market witnessed notable expansion, and this trajectory is projected to continue with a value CAGR of 8.0% through the forecast period, surpassing US$ 240 Mn in 2024.

Driving Factors

The growth of the in vitro protein expression market can be attributed to several factors. Increasing demand for continuous-exchange in vitro protein synthesis, coupled with rising consumption of in vitro protein systems in bio-pharma and biotech companies, is fueling market expansion. Moreover, the demand for simple and effective protein production methods, along with technological advancements, further propels market growth.

Research and Development Initiatives

Strong research and development initiatives associated with in vitro protein synthesis have significantly expanded the adoption of in vitro protein expression systems. These systems find increased utilization in various applications, including protein library generation for customized drug development, functional genomic studies, and the expression of virus-like particles, among others. Additionally, in vitro protein expressions serve as potential tools in genetic diagnostics and can be used alongside truncated proteins for mutation detection in marker genes.

Market Segmentation

Within the market, the E.coli system segment holds a major share. Widely used due to its cost-effectiveness and higher protein yield, the E.coli system segment is anticipated to continue its dominance. It is estimated to expand at a remarkable CAGR of 7.1% throughout the assessment period, reaching a market valuation just under US$ 115 Mn in 2024.

The mammalian system segment, while the second-largest, is expected to contribute significantly to market growth, with a high rate of expansion anticipated during the forecast period.

In contrast, the insect cells system and wheat germ system segments are comparatively lower in valuation but poised to register moderate CAGR during the forecast period. Of these, the wheat germ system segment holds a relatively larger share compared to the insect cells system segment.

Regional Insights

In North America, particularly the United States, the in vitro protein expression market is witnessing rapid adoption, with E.coli and mammalian systems leading the growth. The mammalian system segment is expected to experience higher demand in the coming years, with a stellar CAGR projected during the forecast period. Similarly, the E.coli system segment in North America is expected to register a robust CAGR of 5.8% during the forecast period.

Competitive Analysis

Key companies functioning in the global in vitro protein expression market including:

Thermo Fisher Scientific, Inc.
Takara Bio Company
New England Biolabs
Promega Corporation
Jena Bioscience GmbH
GeneCopoeia, Inc.
Biotechrabbit GmbH
Cube Biotech GmbH
CellFree Sciences Co., Ltd.
Bioneer Corporation
Others.

Market Segmentation

Product Type

coli System
Rabbit Reticulocytes System
Wheat Germ System
Insect Cells System
Mammalian System

Expression Mode

Continuous Flow Expression
Batch Expression

End User

Biotechnological Companies
Pharmaceutical Companies
Contract Research Organizations
Academic and Research Institutes

Application

Enzyme Engineering
Protein Labeling
Protein-Protein Interaction
Protein Purification

Region

North America
Latin America
Europe
Asia Pacific
MEA

1. Executive Summary

1.1. Global In Vitro Protein Expression Market Snapshot
1.2. Future Projections
1.3. Key Market Trends
1.4. Regional Snapshot, by Value, 2023
1.5. Analyst Recommendations

2. Market Overview

2.1. Market Definitions and Segmentations
2.2. Market Dynamics
- 2.2.1. Drivers
- 2.2.2. Restraints
- 2.2.3. Market Opportunities
2.3. Value Chain Analysis
2.4. Porter's Five Forces Analysis
2.5. COVID-19 Impact Analysis
- 2.5.1. Supply
- 2.5.2. Demand
2.6. Impact of Ukraine-Russia Conflict
2.7. Economic Overview
- 2.7.1. World Economic Projections
2.8. PESTLE Analysis

3. Global In Vitro Protein Expression Market Outlook, 2018 - 2031

3.1. Global In Vitro Protein Expression Market Outlook, by Product Type, Value (US$ Mn), 2018 - 2031
- 3.1.1. Key Highlights
  - 3.1.1.1. E-coli In-Vitro Protein Expression System
  - 3.1.1.2. Rabbit Reticulocytes In-Vitro Protein Expression System
  - 3.1.1.3. Wheat Germ In-Vitro Protein Expression System
  - 3.1.1.4. Insect Cells In-Vitro Protein Expression System
  - 3.1.1.5. Mammalian In-Vitro Protein Expression System
3.2. Global In Vitro Protein Expression Market Outlook, by Expression Mode, Value (US$ Mn), 2018 - 2031
- 3.2.1. Key Highlights
  - 3.2.1.1. Continuous Flow Expression
  - 3.2.1.2. Batch Expression
3.3. Global In Vitro Protein Expression Market Outlook, by Application, Value (US$ Mn), 2018 - 2031
- 3.3.1. Key Highlights
  - 3.3.1.1. Enzyme Engineering
  - 3.3.1.2. Protein Labeling
  - 3.3.1.3. Protein-Protein Interaction
  - 3.3.1.4. Protein Purification
3.4. Global In Vitro Protein Expression Market Outlook, by End User, Value (US$ Mn), 2018 - 2031
- 3.4.1. Key Highlights
  - 3.4.1.1. Biotechnological Companies
  - 3.4.1.2. Pharmaceutical Companies
  - 3.4.1.3. Contract Research Organizations
  - 3.4.1.4. Academic and Research Institutes
3.5. Global In Vitro Protein Expression Market Outlook, by Region, Value (US$ Mn), 2018 - 2031
- 3.5.1. Key Highlights
  - 3.5.1.1. North America
  - 3.5.1.2. Europe
  - 3.5.1.3. Asia Pacific
  - 3.5.1.4. Latin America
  - 3.5.1.5. Middle East & Africa

4. North America In Vitro Protein Expression Market Outlook, 2018 - 2031

4.1. North America In Vitro Protein Expression Market Outlook, by Product Type, Value (US$ Mn), 2018 - 2031
- 4.1.1. Key Highlights
  - 4.1.1.1. E-coli In-Vitro Protein Expression System
  - 4.1.1.2. Rabbit Reticulocytes In-Vitro Protein Expression System
  - 4.1.1.3. Wheat Germ In-Vitro Protein Expression System
  - 4.1.1.4. Insect Cells In-Vitro Protein Expression System
  - 4.1.1.5. Mammalian In-Vitro Protein Expression System
4.2. North America In Vitro Protein Expression Market Outlook, by Expression Mode, Value (US$ Mn), 2018 - 2031
- 4.2.1. Key Highlights
  - 4.2.1.1. Continuous Flow Expression
  - 4.2.1.2. Batch Expression
4.3. North America In Vitro Protein Expression Market Outlook, by Application, Value (US$ Mn), 2018 - 2031
- 4.3.1. Key Highlights
  - 4.3.1.1. Enzyme Engineering
  - 4.3.1.2. Protein Labeling
  - 4.3.1.3. Protein-Protein Interaction
  - 4.3.1.4. Protein Purification
4.4. North America In Vitro Protein Expression Market Outlook, by End User, Value (US$ Mn), 2018 - 2031
- 4.4.1. Key Highlights
  - 4.4.1.1. Biotechnological Companies
  - 4.4.1.2. Pharmaceutical Companies
  - 4.4.1.3. Contract Research Organizations
  - 4.4.1.4. Academic and Research Institutes
4.5. North America In Vitro Protein Expression Market Outlook, by Country, Value (US$ Mn), 2018 - 2031
- 4.5.1. Key Highlights
  - 4.5.1.1. U.S. In Vitro Protein Expression Market by Product Type, Value (US$ Mn), 2018 - 2031
  - 4.5.1.2. U.S. In Vitro Protein Expression Market by Expression Mode, Value (US$ Mn), 2018 - 2031
  - 4.5.1.3. U.S. In Vitro Protein Expression Market by Application, Value (US$ Mn), 2018 - 2031
  - 4.5.1.4. U.S. In Vitro Protein Expression Market by End User, Value (US$ Mn), 2018 - 2031
  - 4.5.1.5. Canada In Vitro Protein Expression Market by Product Type, Value (US$ Mn), 2018 - 2031
  - 4.5.1.6. Canada In Vitro Protein Expression Market by Expression Mode, Value (US$ Mn), 2018 - 2031
  - 4.5.1.7. Canada In Vitro Protein Expression Market by Application, Value (US$ Mn), 2018 - 2031
  - 4.5.1.8. Canada In Vitro Protein Expression Market by End User, Value (US$ Mn), 2018 - 2031
- 4.5.2. BPS Analysis/Market Attractiveness Analysis

5. Europe In Vitro Protein Expression Market Outlook, 2018 - 2031

5.1. Europe In Vitro Protein Expression Market Outlook, by Product Type, Value (US$ Mn), 2018 - 2031
- 5.1.1. Key Highlights
  - 5.1.1.1. E-coli In-Vitro Protein Expression System
  - 5.1.1.2. Rabbit Reticulocytes In-Vitro Protein Expression System
  - 5.1.1.3. Wheat Germ In-Vitro Protein Expression System
  - 5.1.1.4. Insect Cells In-Vitro Protein Expression System
  - 5.1.1.5. Mammalian In-Vitro Protein Expression System
5.2. Europe In Vitro Protein Expression Market Outlook, by Expression Mode, Value (US$ Mn), 2018 - 2031
- 5.2.1. Key Highlights
  - 5.2.1.1. Continuous Flow Expression
  - 5.2.1.2. Batch Expression
5.3. Europe In Vitro Protein Expression Market Outlook, by Application, Value (US$ Mn), 2018 - 2031
- 5.3.1. Key Highlights
  - 5.3.1.1. Enzyme Engineering
  - 5.3.1.2. Protein Labeling
  - 5.3.1.3. Protein-Protein Interaction
  - 5.3.1.4. Protein Purification
5.4. Europe In Vitro Protein Expression Market Outlook, by End User, Value (US$ Mn), 2018 - 2031
- 5.4.1. Key Highlights
  - 5.4.1.1. Biotechnological Companies
  - 5.4.1.2. Pharmaceutical Companies
  - 5.4.1.3. Contract Research Organizations
  - 5.4.1.4. Academic and Research Institutes
5.5. Europe In Vitro Protein Expression Market Outlook, by Country, Value (US$ Mn), 2018 - 2031
- 5.5.1. Key Highlights
  - 5.5.1.1. Germany In Vitro Protein Expression Market by Product Type, Value (US$ Mn), 2018 - 2031
  - 5.5.1.2. Germany In Vitro Protein Expression Market by Expression Mode, Value (US$ Mn), 2018 - 2031
  - 5.5.1.3. Germany In Vitro Protein Expression Market by Application, Value (US$ Mn), 2018 - 2031
  - 5.5.1.4. Germany In Vitro Protein Expression Market by End User, Value (US$ Mn), 2018 - 2031
  - 5.5.1.5. U.K. In Vitro Protein Expression Market by Product Type, Value (US$ Mn), 2018 - 2031
  - 5.5.1.6. U.K. In Vitro Protein Expression Market by Expression Mode, Value (US$ Mn), 2018 - 2031
  - 5.5.1.7. U.K. In Vitro Protein Expression Market by Application, Value (US$ Mn), 2018 - 2031
  - 5.5.1.8. U.K. In Vitro Protein Expression Market by End User, Value (US$ Mn), 2018 - 2031
  - 5.5.1.9. France In Vitro Protein Expression Market by Product Type, Value (US$ Mn), 2018 - 2031
  - 5.5.1.10. France In Vitro Protein Expression Market by Expression Mode, Value (US$ Mn), 2018 - 2031
  - 5.5.1.11. France In Vitro Protein Expression Market by Application, Value (US$ Mn), 2018 - 2031
  - 5.5.1.12. France In Vitro Protein Expression Market by End User, Value (US$ Mn), 2018 - 2031
  - 5.5.1.13. Italy In Vitro Protein Expression Market by Product Type, Value (US$ Mn), 2018 - 2031
  - 5.5.1.14. Italy In Vitro Protein Expression Market by Expression Mode, Value (US$ Mn), 2018 - 2031
  - 5.5.1.15. Italy In Vitro Protein Expression Market by Application, Value (US$ Mn), 2018 - 2031
  - 5.5.1.16. Italy In Vitro Protein Expression Market by End User, Value (US$ Mn), 2018 - 2031
  - 5.5.1.17. Turkey In Vitro Protein Expression Market by Product Type, Value (US$ Mn), 2018 - 2031
  - 5.5.1.18. Turkey In Vitro Protein Expression Market by Expression Mode, Value (US$ Mn), 2018 - 2031
  - 5.5.1.19. Turkey In Vitro Protein Expression Market by Application, Value (US$ Mn), 2018 - 2031
  - 5.5.1.20. Turkey In Vitro Protein Expression Market by End User, Value (US$ Mn), 2018 - 2031
  - 5.5.1.21. Russia In Vitro Protein Expression Market by Product Type, Value (US$ Mn), 2018 - 2031
  - 5.5.1.22. Russia In Vitro Protein Expression Market by Expression Mode, Value (US$ Mn), 2018 - 2031
  - 5.5.1.23. Russia In Vitro Protein Expression Market by Application, Value (US$ Mn), 2018 - 2031
  - 5.5.1.24. Russia In Vitro Protein Expression Market by End User, Value (US$ Mn), 2018 - 2031
  - 5.5.1.25. Rest of Europe In Vitro Protein Expression Market by Product Type, Value (US$ Mn), 2018 - 2031
  - 5.5.1.26. Rest of Europe In Vitro Protein Expression Market by Expression Mode, Value (US$ Mn), 2018 - 2031
  - 5.5.1.27. Rest of Europe In Vitro Protein Expression Market by Application, Value (US$ Mn), 2018 - 2031
  - 5.5.1.28. Rest of Europe In Vitro Protein Expression Market by End User, Value (US$ Mn), 2018 - 2031
- 5.5.2. BPS Analysis/Market Attractiveness Analysis

6. Asia Pacific In Vitro Protein Expression Market Outlook, 2018 - 2031

6.1. Asia Pacific In Vitro Protein Expression Market Outlook, by Product Type, Value (US$ Mn), 2018 - 2031
- 6.1.1. Key Highlights
  - 6.1.1.1. E-coli In-Vitro Protein Expression System
  - 6.1.1.2. Rabbit Reticulocytes In-Vitro Protein Expression System
  - 6.1.1.3. Wheat Germ In-Vitro Protein Expression System
  - 6.1.1.4. Insect Cells In-Vitro Protein Expression System
  - 6.1.1.5. Mammalian In-Vitro Protein Expression System
6.2. Asia Pacific In Vitro Protein Expression Market Outlook, by Expression Mode, Value (US$ Mn), 2018 - 2031
- 6.2.1. Key Highlights
  - 6.2.1.1. Continuous Flow Expression
  - 6.2.1.2. Batch Expression
6.3. Asia Pacific In Vitro Protein Expression Market Outlook, by Application, Value (US$ Mn), 2018 - 2031
- 6.3.1. Key Highlights
  - 6.3.1.1. Enzyme Engineering
  - 6.3.1.2. Protein Labeling
  - 6.3.1.3. Protein-Protein Interaction
  - 6.3.1.4. Protein Purification
6.4. Asia Pacific In Vitro Protein Expression Market Outlook, by End User, Value (US$ Mn), 2018 - 2031
- 6.4.1. Key Highlights
  - 6.4.1.1. Biotechnological Companies
  - 6.4.1.2. Pharmaceutical Companies
  - 6.4.1.3. Contract Research Organizations
  - 6.4.1.4. Academic and Research Institutes
6.5. Asia Pacific In Vitro Protein Expression Market Outlook, by Country, Value (US$ Mn), 2018 - 2031
- 6.5.1. Key Highlights
  - 6.5.1.1. China In Vitro Protein Expression Market by Product Type, Value (US$ Mn), 2018 - 2031
  - 6.5.1.2. China In Vitro Protein Expression Market by Expression Mode, Value (US$ Mn), 2018 - 2031
  - 6.5.1.3. China In Vitro Protein Expression Market by Application, Value (US$ Mn), 2018 - 2031
  - 6.5.1.4. China In Vitro Protein Expression Market by End User, Value (US$ Mn), 2018 - 2031
  - 6.5.1.5. Japan In Vitro Protein Expression Market by Product Type, Value (US$ Mn), 2018 - 2031
  - 6.5.1.6. Japan In Vitro Protein Expression Market by Expression Mode, Value (US$ Mn), 2018 - 2031
  - 6.5.1.7. Japan In Vitro Protein Expression Market by Application, Value (US$ Mn), 2018 - 2031
  - 6.5.1.8. Japan In Vitro Protein Expression Market by End User, Value (US$ Mn), 2018 - 2031
  - 6.5.1.9. South Korea In Vitro Protein Expression Market by Product Type, Value (US$ Mn), 2018 - 2031
  - 6.5.1.10. South Korea In Vitro Protein Expression Market by Expression Mode, Value (US$ Mn), 2018 - 2031
  - 6.5.1.11. South Korea In Vitro Protein Expression Market by Application, Value (US$ Mn), 2018 - 2031
  - 6.5.1.12. South Korea In Vitro Protein Expression Market by End User, Value (US$ Mn), 2018 - 2031
  - 6.5.1.13. India In Vitro Protein Expression Market by Product Type, Value (US$ Mn), 2018 - 2031
  - 6.5.1.14. India In Vitro Protein Expression Market by Expression Mode, Value (US$ Mn), 2018 - 2031
  - 6.5.1.15. India In Vitro Protein Expression Market by Application, Value (US$ Mn), 2018 - 2031
  - 6.5.1.16. India In Vitro Protein Expression Market by End User, Value (US$ Mn), 2018 - 2031
  - 6.5.1.17. Southeast Asia In Vitro Protein Expression Market by Product Type, Value (US$ Mn), 2018 - 2031
  - 6.5.1.18. Southeast Asia In Vitro Protein Expression Market by Expression Mode, Value (US$ Mn), 2018 - 2031
  - 6.5.1.19. Southeast Asia In Vitro Protein Expression Market by Application, Value (US$ Mn), 2018 - 2031
  - 6.5.1.20. Southeast Asia In Vitro Protein Expression Market by End User, Value (US$ Mn), 2018 - 2031
  - 6.5.1.21. Rest of Asia Pacific In Vitro Protein Expression Market by Product Type, Value (US$ Mn), 2018 - 2031
  - 6.5.1.22. Rest of Asia Pacific In Vitro Protein Expression Market by Expression Mode, Value (US$ Mn), 2018 - 2031
  - 6.5.1.23. Rest of Asia Pacific In Vitro Protein Expression Market by Application, Value (US$ Mn), 2018 - 2031
  - 6.5.1.24. Rest of Asia Pacific In Vitro Protein Expression Market by End User, Value (US$ Mn), 2018 - 2031
- 6.5.2. BPS Analysis/Market Attractiveness Analysis

7. Latin America In Vitro Protein Expression Market Outlook, 2018 - 2031

7.1. Latin America In Vitro Protein Expression Market Outlook, by Product Type, Value (US$ Mn), 2018 - 2031
- 7.1.1. Key Highlights
  - 7.1.1.1. E-coli In-Vitro Protein Expression System
  - 7.1.1.2. Rabbit Reticulocytes In-Vitro Protein Expression System
  - 7.1.1.3. Wheat Germ In-Vitro Protein Expression System
  - 7.1.1.4. Insect Cells In-Vitro Protein Expression System
  - 7.1.1.5. Mammalian In-Vitro Protein Expression System
7.2. Latin America In Vitro Protein Expression Market Outlook, by Expression Mode, Value (US$ Mn), 2018 - 2031
- 7.2.1. Key Highlights
  - 7.2.1.1. Continuous Flow Expression
  - 7.2.1.2. Batch Expression
7.3. Latin America In Vitro Protein Expression Market Outlook, by Application, Value (US$ Mn), 2018 - 2031
- 7.3.1. Key Highlights
  - 7.3.1.1. Enzyme Engineering
  - 7.3.1.2. Protein Labeling
  - 7.3.1.3. Protein-Protein Interaction
  - 7.3.1.4. Protein Purification
7.4. Latin America In Vitro Protein Expression Market Outlook, by End User, Value (US$ Mn), 2018 - 2031
- 7.4.1. Key Highlights
  - 7.4.1.1. Biotechnological Companies
  - 7.4.1.2. Pharmaceutical Companies
  - 7.4.1.3. Contract Research Organizations
  - 7.4.1.4. Academic and Research Institutes
7.5. Latin America In Vitro Protein Expression Market Outlook, by Country, Value (US$ Mn), 2018 - 2031
- 7.5.1. Key Highlights
  - 7.5.1.1. Brazil In Vitro Protein Expression Market by Product Type, Value (US$ Mn), 2018 - 2031
  - 7.5.1.2. Brazil In Vitro Protein Expression Market by Expression Mode, Value (US$ Mn), 2018 - 2031
  - 7.5.1.3. Brazil In Vitro Protein Expression Market by Application, Value (US$ Mn), 2018 - 2031
  - 7.5.1.4. Brazil In Vitro Protein Expression Market by End User, Value (US$ Mn), 2018 - 2031
  - 7.5.1.5. Mexico In Vitro Protein Expression Market by Product Type, Value (US$ Mn), 2018 - 2031
  - 7.5.1.6. Mexico In Vitro Protein Expression Market by Expression Mode, Value (US$ Mn), 2018 - 2031
  - 7.5.1.7. Mexico In Vitro Protein Expression Market by Application, Value (US$ Mn), 2018 - 2031
  - 7.5.1.8. Mexico In Vitro Protein Expression Market by End User, Value (US$ Mn), 2018 - 2031
  - 7.5.1.9. Argentina In Vitro Protein Expression Market by Product Type, Value (US$ Mn), 2018 - 2031
  - 7.5.1.10. Argentina In Vitro Protein Expression Market by Expression Mode, Value (US$ Mn), 2018 - 2031
  - 7.5.1.11. Argentina In Vitro Protein Expression Market by Application, Value (US$ Mn), 2018 - 2031
  - 7.5.1.12. Argentina In Vitro Protein Expression Market by End User, Value (US$ Mn), 2018 - 2031
  - 7.5.1.13. Rest of Latin America In Vitro Protein Expression Market by Product Type, Value (US$ Mn), 2018 - 2031
  - 7.5.1.14. Rest of Latin America In Vitro Protein Expression Market by Expression Mode, Value (US$ Mn), 2018 - 2031
  - 7.5.1.15. Rest of Latin America In Vitro Protein Expression Market by Application, Value (US$ Mn), 2018 - 2031
  - 7.5.1.16. Rest of Latin America In Vitro Protein Expression Market by End User, Value (US$ Mn), 2018 - 2031
- 7.5.2. BPS Analysis/Market Attractiveness Analysis

8. Middle East & Africa In Vitro Protein Expression Market Outlook, 2018 - 2031

8.1. Middle East & Africa In Vitro Protein Expression Market Outlook, by Product Type, Value (US$ Mn), 2018 - 2031
- 8.1.1. Key Highlights
  - 8.1.1.1. E-coli In-Vitro Protein Expression System
  - 8.1.1.2. Rabbit Reticulocytes In-Vitro Protein Expression System
  - 8.1.1.3. Wheat Germ In-Vitro Protein Expression System
  - 8.1.1.4. Insect Cells In-Vitro Protein Expression System
  - 8.1.1.5. Mammalian In-Vitro Protein Expression System
8.2. Middle East & Africa In Vitro Protein Expression Market Outlook, by Expression Mode, Value (US$ Mn), 2018 - 2031
- 8.2.1. Key Highlights
  - 8.2.1.1. Continuous Flow Expression
  - 8.2.1.2. Batch Expression
8.3. Middle East & Africa In Vitro Protein Expression Market Outlook, by Application, Value (US$ Mn), 2018 - 2031
- 8.3.1. Key Highlights
  - 8.3.1.1. Enzyme Engineering
  - 8.3.1.2. Protein Labeling
  - 8.3.1.3. Protein-Protein Interaction
  - 8.3.1.4. Protein Purification
8.4. Middle East & Africa In Vitro Protein Expression Market Outlook, by End User, Value (US$ Mn), 2018 - 2031
- 8.4.1. Key Highlights
  - 8.4.1.1. Biotechnological Companies
  - 8.4.1.2. Pharmaceutical Companies
  - 8.4.1.3. Contract Research Organizations
  - 8.4.1.4. Academic and Research Institutes
8.5. Middle East & Africa In Vitro Protein Expression Market Outlook, by Country, Value (US$ Mn), 2018 - 2031
- 8.5.1. Key Highlights
  - 8.5.1.1. GCC In Vitro Protein Expression Market by Product Type, Value (US$ Mn), 2018 - 2031
  - 8.5.1.2. GCC In Vitro Protein Expression Market by Expression Mode, Value (US$ Mn), 2018 - 2031
  - 8.5.1.3. GCC In Vitro Protein Expression Market by Application, Value (US$ Mn), 2018 - 2031
  - 8.5.1.4. GCC In Vitro Protein Expression Market by End User, Value (US$ Mn), 2018 - 2031
  - 8.5.1.5. South Africa In Vitro Protein Expression Market by Product Type, Value (US$ Mn), 2018 - 2031
  - 8.5.1.6. South Africa In Vitro Protein Expression Market by Expression Mode, Value (US$ Mn), 2018 - 2031
  - 8.5.1.7. South Africa In Vitro Protein Expression Market by Application, Value (US$ Mn), 2018 - 2031
  - 8.5.1.8. South Africa In Vitro Protein Expression Market by End User, Value (US$ Mn), 2018 - 2031
  - 8.5.1.9. Egypt In Vitro Protein Expression Market by Product Type, Value (US$ Mn), 2018 - 2031
  - 8.5.1.10. Egypt In Vitro Protein Expression Market by Expression Mode, Value (US$ Mn), 2018 - 2031
  - 8.5.1.11. Egypt In Vitro Protein Expression Market by Application, Value (US$ Mn), 2018 - 2031
  - 8.5.1.12. Egypt In Vitro Protein Expression Market by End User, Value (US$ Mn), 2018 - 2031
  - 8.5.1.13. Nigeria In Vitro Protein Expression Market by Product Type, Value (US$ Mn), 2018 - 2031
  - 8.5.1.14. Nigeria In Vitro Protein Expression Market by Expression Mode, Value (US$ Mn), 2018 - 2031
  - 8.5.1.15. Nigeria In Vitro Protein Expression Market by Application, Value (US$ Mn), 2018 - 2031
  - 8.5.1.16. Nigeria In Vitro Protein Expression Market by End User, Value (US$ Mn), 2018 - 2031
  - 8.5.1.17. Rest of Middle East & Africa In Vitro Protein Expression Market by Product Type, Value (US$ Mn), 2018 - 2031
  - 8.5.1.18. Rest of Middle East & Africa In Vitro Protein Expression Market by Expression Mode, Value (US$ Mn), 2018 - 2031
  - 8.5.1.19. Rest of Middle East & Africa In Vitro Protein Expression Market by Application, Value (US$ Mn), 2018 - 2031
  - 8.5.1.20. Rest of Middle East & Africa In Vitro Protein Expression Market by End User, Value (US$ Mn), 2018 - 2031
- 8.5.2. BPS Analysis/Market Attractiveness Analysis

9. Competitive Landscape

9.1. Product Type vs Expression Mode Heatmap
9.2. Manufacturer vs Expression Mode Heatmap
9.3. Company Market Share Analysis, 2023
9.4. Competitive Dashboard
9.5. Company Profiles
- 9.5.1. Thermo Fisher Scientific, Inc.
  - 9.5.1.1. Company Overview
  - 9.5.1.2. Product Type Portfolio
  - 9.5.1.3. Financial Overview
  - 9.5.1.4. Business Strategies and Development
- 9.5.2. Takara Bio Company
  - 9.5.2.1. Company Overview
  - 9.5.2.2. Product Type Portfolio
  - 9.5.2.3. Financial Overview
  - 9.5.2.4. Business Strategies and Development
- 9.5.3. New England Biolabs
  - 9.5.3.1. Company Overview
  - 9.5.3.2. Product Type Portfolio
  - 9.5.3.3. Financial Overview
  - 9.5.3.4. Business Strategies and Development
- 9.5.4. Promega Corporation
  - 9.5.4.1. Company Overview
  - 9.5.4.2. Product Type Portfolio
  - 9.5.4.3. Financial Overview
  - 9.5.4.4. Business Strategies and Development
- 9.5.5. Jena Bioscience GmbH
  - 9.5.5.1. Company Overview
  - 9.5.5.2. Product Type Portfolio
  - 9.5.5.3. Financial Overview
  - 9.5.5.4. Business Strategies and Development
- 9.5.6. GeneCopoeia, Inc.
  - 9.5.6.1. Company Overview
  - 9.5.6.2. Product Type Portfolio
  - 9.5.6.3. Financial Overview
  - 9.5.6.4. Business Strategies and Development
- 9.5.7. Biotechrabbit GmbH
  - 9.5.7.1. Company Overview
  - 9.5.7.2. Product Type Portfolio
  - 9.5.7.3. Financial Overview
  - 9.5.7.4. Business Strategies and Development
- 9.5.8. Cube Biotech GmbH
  - 9.5.8.1. Company Overview
  - 9.5.8.2. Product Type Portfolio
  - 9.5.8.3. Financial Overview
  - 9.5.8.4. Business Strategies and Development
- 9.5.9. CellFree Sciences Co., Ltd.
  - 9.5.9.1. Company Overview
  - 9.5.9.2. Product Type Portfolio
  - 9.5.9.3. Financial Overview
  - 9.5.9.4. Business Strategies and Development
- 9.5.10. Bioneer Corporation
  - 9.5.10.1. Company Overview
  - 9.5.10.2. Product Type Portfolio
  - 9.5.10.3. Financial Overview
  - 9.5.10.4. Business Strategies and Development

10. Appendix

10.1. Research Methodology
10.2. Report Assumptions
10.3. Acronyms and Abbreviations